Table 3.
Hyperuricemia and in-hospital clinical complications.
| Complication | Hyperuricemic group (n = 211) | Normouricemic group (n = 577) | p-value |
| CI-AKI (%) | 17 (8.1) | 8 (1.4) | <0.001 |
| Death (%) | 5 (2.4) | 2 (0.3) | 0.007 |
| Cause of death | 0.001 | ||
| Cardiogenic shock (%) | 0 | 1 (0.2) | |
| Cardiac rupture (%) | 1 (0.5) | 1 (0.2) | |
| Arrhythmia (VT/VF) (%) | 2 (0.9) | 0 | |
| Non-cardiac cause (%) | 2 (0.9) | 0 | |
| Renal replacement therapy (%) | 3 (1.4) | 0 | 0.004 |
| 2nd myocardial infarction (%) | 1 (0.5) | 0 | 0.098 |
| Target revascularization (%) | 1 (0.5) | 2 (0.3) | 0.797 |
| Acute heart failure (%) | 6 (2.8) | 1 (1.0) | 0.095 |
| IABP (%) | 13 (6.2) | 16 (2.8) | 0.025 |
| Mechanical ventilation (%) | 6 (2.8) | 5 (0.9) | 0.078 |
| 2nd angina (%) | 7 (3.3) | 37 (6.4) | 0.094 |
| Tachyarrhythmia (%) | 7 (3.3) | 12 (2.1) | 0.316 |
| Hypotension (%) | 11 (5.3) | 11 (1.9) | 0.011 |
| Cerebrovascular accident (%) | 1 (0.5) | 1 (0.2) | 0.458 |
VT/VF, ventricular tachycardia/ventricular fibrillation; IABP, intra-aortic balloon pump.